// App-Quantinova.ai

196 : Audit examining the difference in clinical outcomes amongst originator biologic treated patients with RA, PsA and AxSpA who were switched to biosimilar versions and monitored routinely at St George’s University Hospital NHS Trust

Researchers

Presenter

  • Saadia S Ali

Principal Investigators

  • Diane Hill

  • Nidhi Sofat

Medical Centers

  • Rheumatology, St George's Hospital, London, UNITED KINGDOM

  • Institute for Infection and Immunity, St George’s, University of London, London, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • Etanercept biosimilar

  • Infliximab Biosimilar

  • Etanercept

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved